Astellas Pharma

From Verify.Wiki
Jump to: navigation, search

The Astellas Group’s business philosophy has three elements — raison d'être, mission and beliefs.

Raison D'être

Contribute toward improving the health of people around the world through the provision of innovative and reliable pharmaceutical products

  • To go beyond all others in exploring and tapping the potential of the life sciences.
  • To continue tackling new challenges and creating innovative pharmaceutical products.
  • To deliver quality products along with accurate information and retain solid credibility among customers.
  • To support healthy living for people around the world.
  • To continue shining on the global pharmaceutical field.

Mission

Sustainable enhancement of enterprise value

  • Astellas will seek to enhance its enterprise value in a sustainable manner.
  • Astellas will seek to be the company of choice among all its stakeholders, including its customers, shareholders, employees, and the global community.
  • Astellas will strive to gain the trust of all stakeholders and thereby enhance its enterprise value.

Beliefs

Our “beliefs” provide the code of conduct we prize at all times. Astellas will always be a group of people who act upon these beliefs.

High Sense of Ethics We will always manage our business with the highest sense of ethics.

Customer Focus We will always seek to understand customer needs and our focus will always be on achieving customer satisfaction.

Creativity We will not be complacent and will always seek to innovate to create new value.

Competitive Focus Our eyes will always be directed to the outside world, and we will continue to create better value faster.

Astellas promises to perform its obligations toward all stakeholders by acting ethically and seeking to actively disclose information.

Example.jpg
https://www.astellas.com
Type Public / Private
Founded 2005
Slogan Contribute towards improving the health of people around the world through the provision of innovative and reliable pharmaceutical products
Headquarters Tokyo, Japan
Key people Kenji Yasukawa

History

Controversies

Top 5 Recent Tweets

DateAuthorComment
November 26, 2022Public_CitizenAstellas is charging $189,000 for Xtandi, a cancer treatment.

The cost of the same drug in other countries:

Japan… https://t.co/NuMwIP4dlw
December 02, 2022sci_ntdsGreat news! The European Medicines Agency validates the application of our potential new treatment option for… https://t.co/oiMZ5KiUbS
December 02, 2022dragon38073853ASTELLAS PHARMA WO2022230912 - SUBSTITUTED TRIAZINE COMPOUND

NLRP3 inhibitors

https://t.co/t3BIsZgbhc https://t.co/hw4Ot1GGfE
December 03, 2022AstellasUSAs the pharma industry rethinks clinical trial approaches, Marie Rosenfeld, SVP, Head of Clinical Science shares he… https://t.co/RyFZj1o8eV


Top 5 Recent News Headlines

Top 5 Lifetime Tweets

Top 5 Lifetime News Headlines

Verification history